Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ortho-hydroxybenzoic acid or derivative doai
Patent
1997-12-18
1999-07-06
Mach, D. Margaret M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ortho-hydroxybenzoic acid or derivative doai
514160, 514161, 514162, 514163, 514167, A61K 3147, A61K 31475, A61K 3149
Patent
active
059197765
ABSTRACT:
The present invention is directed to aminoquinolines of Formula I: ##STR1## (wherein R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are defined herein) which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptors CCR-1, CCR-2, CCR-2A, CCR-2B, CCR-3, CCR-4, CCR-5, CXCR-3, and/or CXCR-4.
REFERENCES:
patent: 5441963 (1995-08-01), McDonald
patent: 5506235 (1996-04-01), Moyer
Chemical Abstracts 116:51112, Lanza, 1992.
Medline 96210126, Legler, 1996.
Medline 94089760, Eaves, 1993.
Medline 94044787, Hori, 1993.
Chemical Abstracts 124:143381, Bennett, 1995.
Chemical Abstracts 124:199641, Toggas, 1996.
Hagmann William K.
Springer Martin S.
M. Mach D. Margaret
Merck & Co. , Inc.
Rose David L.
Thies J. Eric
LandOfFree
Substituted aminoquinolines as modulators of chemokine receptor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted aminoquinolines as modulators of chemokine receptor , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted aminoquinolines as modulators of chemokine receptor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-899134